I

Icon

Global drug and device development services

Senior Director Cardiometabolic - Drug Development Services

Clinical Research OperationsConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • Deep, recognized expertise in Cardiometabolic and liver disease drug development.
  • Strong understanding of Cardiometabolic clinical trial design, biomarkers, endpoints (including fibrosis staging and histologic and non-invasive markers), and evolving therapeutic landscapes such as MASLD/MASH, alcohol-associated liver disease, cirrhosis, immuno-Cardiometabolic approaches, and antiviral therapies.
  • Proven ability to operate in a strategic, client-facing, consultative environment within pharmaceutical or clinical research settings.
  • Experience engaging and influencing senior scientific and clinical stakeholders across industry and academia.
  • Excellent communication and presentation skills, including the ability to translate complex Cardiometabolic data into clear, actionable development insights.
  • Collaborative, global mindset with strong cross-functional leadership capability.
  • MD required; specialization or substantial clinical/research experience in Cardiometabolic diseases is ideal.
  • Legal right to work in the country where the role is based.

Responsibilities

  • Lead strategic Cardiometabolic drug development design, delivering tailored, asset-focused solutions across liver diseases including MASLD/MASH, alcohol-associated liver disease (ALD), cirrhosis, viral hepatitis, and other chronic and rare liver conditions such as PBC, PSC, and PFIC.
  • Own end-to-end protocol development, including design, scientific review, and evaluation for Cardiometabolic clinical trials across Phases I–IV.
  • Partner directly with senior client stakeholders, including CMOs, therapeutic area heads, and clinical development leadership, to provide expert guidance on Cardiometabolic development strategy and data interpretation.
  • Act as scientific and strategic lead in proposal development, study strategy, and bid defense activities within Cardiometabolic.
  • Build and maintain strong relationships with Cardiometabolic key opinion leaders, advisory boards, and relevant regulatory authorities.
  • Contribute to the development of Cardiometabolic-focused service offerings, supporting innovation and growth in liver disease drug development capabilities.
  • Provide training, mentorship, and thought leadership in Cardiometabolic to internal teams and external partners.
  • Participate in portfolio reviews, governance discussions, and scientific oversight of Cardiometabolic programs.
  • Support operational teams with high-level scientific input, including investigator meetings and Cardiometabolic-specific study discussions.
  • Represent the organization at Cardiometabolic congresses and scientific forums to promote clinical excellence and scientific leadership.

About the Company

Icon

Global drug and device development services

This company provides consulting, development, and commercialization support for drugs and medical devices through a global network of offices. Its team across 53 countries offers end-to-end services, from strategy and regulatory work to manufacturing and market access, helping clients shorten development time, lower costs, and raise quality. It differentiates itself with wide geographic reach and a clear focus on reducing time to market and cost while leveraging deep experience across many therapeutic areas. Its goal is to help clients accelerate the development of life-saving products and improve quality of life by delivering reliable information, practical solutions, and solid performance.

Company size
10,001+
Company stage
IPO
Headquarters
Ireland
Founded
1990

Recently Posted Jobs

Explore more opportunities at Icon

See more jobs